首页> 外文期刊>FEBS letters. >Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin.
【24h】

Expression of adiponectin in choroidal tissue and inhibition of laser induced choroidal neovascularization by adiponectin.

机译:脂联素在脉络膜组织中的表达和脂联素对激光诱导的脉络膜新血管形成的抑制作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The aim of this study was to investigate the role of adiponectin (APN) in a mouse model of laser induced choroidal neovascularization (CNV). We have shown by immunohistochemistry that the expression of APN, adiponectin receptor 1, adiponectin receptor 2 and T cadherin gradually increased from day 1 to day 7 post-laser in laser treated mice compared to controls. Recombinant APN (rAPN) was injected intraperitoneally (i.p., 25 microg/mouse) or intravitreally (2 microg/eye) in lasered mice. Another set of lasered mice received APN peptide via i.p. (75 microg/mouse) or intravitreal (30 microg/eye) route. Control mice received a similar treatment with PBS, control protein or control peptide after laser treatment. We found that in the i.p. and intravitreal injection of rAPN resulted in 78% and 68% inhibition respectively in the size of CNV complex compared to control mice. Similar results were observed when APN peptide was injected intravitreally or i.p. Treatment with rAPN or the peptide resulted in decreased levels of vascular endothelial growth factor. Thus, APN inhibited choroidal angiogenesis and may have therapeutic implications in the treatment of wet age related macular degeneration.
机译:这项研究的目的是调查脂联素(APN)在激光诱导的脉络膜新生血管(CNV)小鼠模型中的作用。通过免疫组织化学我们已经显示,与对照组相比,激光治疗后的小鼠从激光治疗后的第1天到第7天,APN,脂联素受体1,脂联素受体2和T钙粘蛋白的表达逐渐增加。在激光小鼠中腹膜内(即25微克/小鼠)或玻璃体内(2微克/眼)注射重组APN(rAPN)。另一组激光小鼠经腹腔接受APN肽。 (75微克/小鼠)或玻璃体内(30微克/眼)途径。对照小鼠在激光治疗后接受了PBS,对照蛋白或对照肽的类似治疗。我们在i.p.与对照小鼠相比,玻璃体腔注射和rAPN玻璃体内注射分别导致CNV复合体大小的抑制78%和68%。当玻璃体内或腹腔注射APN肽时,观察到相似的结果。用rAPN或肽治疗导致血管内皮生长因子水平降低。因此,APN抑制脉络膜血管生成,并可能在与湿龄相关的黄斑变性的治疗中具有治疗意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号